Taumedis is a pre-seed medical imaging start-up developing multi-modality intraoperative imaging solutions. Our solutions bring the imaging to the patient and are seamlessly integrated into the surgical workflow to improve surgical outcomes without compromise on image quality.

Originally formed in 2018, and officially founded in 2023 by a group of Canadian scientists and engineers who are passionate about medical imaging, the name Taumedis is an acronym for tau Medical Imaging Solutions, where the Greek letter tau (τ) has significance in both magnetic resonance imaging as well as a variety of neurodegenerative diseases. With over 100 years of collective experience in the medical imaging field, the τauMEDIS team strives to provide the highest quality medical imaging solutions to hospitals, clinics, and research facilities, globally.

Winnipeg is the capital city of the Canadian province Manitoba, located roughly one hour north of the Canada/U.S.A. border, and approximately at the geographic center of North America. Winnipeg has a heritage of medical imaging R&D that stems back to the National Research Council Institute for Biodiagnostics (NRC-IBD), a research laboratory established in 1992 that aimed to investigate and develop non-invasive medical diagnostic technology for the prevention, early diagnosis, and improved treatment and prognosis of diseases. The NRC-IBD focused on the areas of magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and infrared spectroscopy (IRS), and spawned a variety of technological innovations that stood at the forefront of their respective modalities.